Expand AGIO Menu
AGIO MENU

AGIO Latest Press Releases

-- April 6, 2026 --

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- April 1, 2026 --

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky PRNewswire 9:00 AM

-- March 31, 2026 --

AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money PRNewswire 9:00 AM
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA Globe Newswire 7:00 AM

-- March 25, 2026 --

AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing Investigation PRNewswire 9:01 AM

-- March 18, 2026 --

ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation PRNewswire 9:01 AM

-- March 17, 2026 --

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gross Law Firm Regarding an Ongoing Investigation PRNewswire 9:01 AM

-- March 11, 2026 --

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation PRNewswire 9:00 AM

-- March 10, 2026 --

Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIO PRNewswire 9:01 AM

-- March 4, 2026 --

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO PRNewswire 9:00 AM

-- March 3, 2026 --

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO PRNewswire 9:00 AM

-- March 2, 2026 --

Agios' PYRUKYND (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates Globe Newswire 7:00 AM

-- February 12, 2026 --

Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 6:30 AM

-- January 26, 2026 --

Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- January 12, 2026 --

Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth Globe Newswire 7:00 AM

-- January 5, 2026 --

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 Globe Newswire 7:00 AM

-- December 23, 2025 --

U.S. FDA Approves Agios' AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia Globe Newswire 7:45 PM

-- December 8, 2025 --

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes